Genic Co., Ltd. (KOSDAQ:123330)
South Korea · Delayed Price · Currency is KRW 31,050
-200 (-0.64%)
At close: Apr 1, 2026
Genic Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 18,887 | 7,563 | -4,411 | -3,340 | -4,331 |
Depreciation & Amortization | 1,969 | 1,637 | 1,801 | 1,883 | 2,313 |
Loss (Gain) From Sale of Assets | 0.01 | -2.99 | 0.01 | -0.74 | -816.66 |
Asset Writedown & Restructuring Costs | - | - | - | 354.74 | - |
Provision & Write-off of Bad Debts | 0.92 | 336.28 | -1.39 | -22.38 | -176.65 |
Other Operating Activities | -3,166 | -1,674 | 1,221 | 1,693 | 6,068 |
Change in Accounts Receivable | 6,220 | -9,398 | 70.19 | 925.95 | 1,169 |
Change in Inventory | -5,374 | -3,736 | -144.14 | 184.63 | -5,284 |
Change in Accounts Payable | 2,262 | 2,089 | 607.64 | 94.52 | -592.9 |
Change in Other Net Operating Assets | -147.33 | 3,458 | 588.76 | -1,587 | 4,221 |
Operating Cash Flow | 20,651 | 272.46 | -268.19 | 186.42 | 2,570 |
Operating Cash Flow Growth | 7479.36% | - | - | -92.75% | 1108.47% |
Capital Expenditures | -2,671 | -1,651 | -841.45 | -1,423 | -649.12 |
Sale of Property, Plant & Equipment | - | 3 | - | - | 12,921 |
Sale (Purchase) of Intangibles | -12.84 | - | - | - | -1.71 |
Investment in Securities | - | - | 2,535 | -2,610 | - |
Other Investing Activities | -705 | 120 | 65 | 120 | -209.76 |
Investing Cash Flow | -3,389 | -1,519 | 1,771 | -3,890 | 12,139 |
Short-Term Debt Issued | 500 | 5,800 | 7,000 | - | 10,000 |
Total Debt Issued | 500 | 5,800 | 7,000 | - | 10,000 |
Short-Term Debt Repaid | -5,500 | -7,800 | - | -10,000 | -13,500 |
Long-Term Debt Repaid | -288.78 | -182.21 | -10,167 | -193.02 | -193.91 |
Total Debt Repaid | -5,789 | -7,982 | -10,167 | -10,193 | -13,694 |
Net Debt Issued (Repaid) | -5,289 | -2,182 | -3,167 | -10,193 | -3,694 |
Issuance of Common Stock | - | 3,000 | - | - | - |
Other Financing Activities | - | -0 | - | - | - |
Financing Cash Flow | -5,289 | 817.8 | -3,167 | -10,193 | -3,694 |
Foreign Exchange Rate Adjustments | -16.38 | 45.21 | -16.65 | 57.27 | 734.73 |
Miscellaneous Cash Flow Adjustments | -0 | 0 | - | 0 | 0 |
Net Cash Flow | 11,957 | -383.19 | -1,681 | -13,839 | 11,750 |
Free Cash Flow | 17,980 | -1,379 | -1,110 | -1,237 | 1,921 |
Free Cash Flow Margin | 22.99% | -2.76% | -3.95% | -3.93% | 5.00% |
Free Cash Flow Per Share | 2298.10 | -188.85 | -161.85 | -180.41 | 280.17 |
Cash Interest Paid | 331.98 | 417.42 | 499.94 | 316.18 | 898.02 |
Cash Income Tax Paid | 202.07 | 0.91 | -0.51 | - | - |
Levered Free Cash Flow | 12,754 | -2,963 | 1,397 | -1,352 | 3,987 |
Unlevered Free Cash Flow | 12,960 | -2,705 | 1,655 | -1,054 | 4,419 |
Change in Working Capital | 2,961 | -7,586 | 1,122 | -381.57 | -486.75 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.